MIND MATTERS RESEARCH LLC
PARTNER EXECUTIVE SUMMARY

Mind Matters Research LLC (MMR) has engaged in the creation, testing, updating and refining of a product and program to alleviate the post-treatment symptoms of breast cancer. The Institute of Medicine (IOM) identified those symptoms as 'chemobrain' (cognitive and memory impairment), fatigue, sleep deprivation, PTSD, anxiety and depression.

In 2005 and 2006, MMR developed and tested the first prototype of the product, a mind-body, imagery-based program entitled "Envision the Rhythms of Life." The research was funded by the National Cancer Institute and resulted in three peer-reviewed medical publications. Outcomes from the Phase I, within-group trial were highly statistically and clinically significant, demonstrating improvements in physical, social, family, emotional and functional well-being. Patient feedback during focus groups demonstrated a high level of enthusiasm from participants for the program and its benefits.

In September, 2008, the National Cancer Institute funded Phase II of this trial. Since that time, the prototype has been updated with the newest scientific findings related to the late-term symptoms of cancer care, recruitment of patients to participate in the trial is underway, and the final product has been completed. Animations, website, artwork, training materials, and videoconference equipment was tested, and in place for the clinical trial by August, 2009. Assessment of treatment outcomes have been strengthened and 'targeted' to include changes in heartrate variability (HRV), as well as all quality of life variables.

There are currently more than 1.9 million breast cancer survivors in the United States. This represents a potential Total Available Market (TAM) of almost 200 million dollars for MMR and its partners. Those numbers grow daily. Breast cancer survivors hunger for an intervention that will help them alleviate the late-term and long-term effects of the cancer treatments that saved their lives. Late-term effects can last for decades unless targeted interventions, based on scientific evidence, are available to mitigate those symptoms. No other program has been created and clinically tested to target these precise symptoms.

Based on the outcomes from Phase I, and the overwhelming interest from survivors during the recruitment process, we anticipate that the product "Envision the Rhythms of Life" will be a highly successful and sought-after program, once testing is completed. We seek partners to assist in providing this program to breast cancer populations across the country.

To view the following files, if you don't already have Microsoft PowerPoint (or a compatible viewer) installed, Visit this page to download the PowerPoint Viewer.

Potential Partner Presentation

Life After Breast Cancer

Clinical Trial Information for NCI grant 2R44CA117597-02A2


Seattle Study Flier

Cancer Study Flier

Talking Points

Physician Referral Form

Study Overview

Return to top